Synthesis and hetero-Michael addition reactions of 2-alkynyl oxazoles and oxazolines
作者:Peter Wipf、Thomas H. Graham
DOI:10.1039/b413604g
日期:——
Stereoselective conjugate additions of alcohols, amines, thiols, and halides to C(2)-alkynyl oxazoles and oxazolines provide a versatile entry to heterocyclic building blocks.
Regioselective Trapping of Terminal Di-, Tri-, and Tetraynes with Benzyl Azide
作者:Thanh Luu、Robert McDonald、Rik R. Tykwinski
DOI:10.1021/ol062522a
日期:2006.12.1
The reaction of benzyl azide with terminal di-, tri-, and tetraynes appended with a range of functional groups has been explored. Standard reaction conditions for BnN3 catalyzed by CuSO(4)(.)5H(2)O gave alkynyl, butadiynyl, and hexatriynyl triazoles in moderate to good yields. The reaction proceeds regioselectively as determined by the X-ray crystallographic analysis of three derivatives (1c, 1d, and 3c), and no evidence of multiple azide addition to the polyyne framework is observed.
[EN] GPX4 INHIBITORS AND USE THEREOF<br/>[FR] INHIBITEURS DE GPX4 ET LEUR UTILISATION
申请人:[en]SONATA THERAPEUTICS, INC.
公开号:WO2024030651A1
公开(公告)日:2024-02-08
The present disclosure provides a compound of Formula (I'), or a pharmaceutically acceptable salt thereof and its use in, e.g. treating a condition, disease, or disorder in which inhibiting GPX4 in a subject is of therapeutic benefit, specifically in treating cancer or autoimmune diseases. This disclosure also features a composition containing the same as well as methods of using and making the same.
CARBOXYLIC ACID ANALOGS AS GPX4 INHIBITORS AND USE THEREOF
申请人:[en]SONATA THERAPEUTICS, INC.
公开号:WO2024151666A1
公开(公告)日:2024-07-18
The present disclosure provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof and its use in,e.g.treating a condition, disease, or disorder in which inhibiting GPX4 in a subject is of therapeutic benefit, specifically in treating cancer or autoimmune diseases. This disclosure also features a composition containing the same as well as methods of using and making the same.